Home › Research › Getting a diagnosis
Diagnostic Accuracy of the Boston Criteria v2.0 in Memory Clinic Patients
Emerson Kropp, Maria Varkanitsa, Thor D. Stein, Katherine W. Turk, Michael Louis Alosco, Yorghos Tripodis, Jose Rafael Romero, Swathi Kiran et al.. Neurology, 2026-08-03
Topic: Risk, prevention and care in population studies
Plain-language summary
Eighty patients were included (mean age: 81 years, interquartile range 74-86 years; 36.2% female, ∼80% with dementia and Alzheimer disease). Using moderate-to-severe CAA as the neuropathologic reference standard, probable CAA by Boston Criteria v1.5 had a sensitivity of 32% (95% CI 15%-50%), specificity 87% (77%-95%), and AUC 0.59 (0.49-0.69). Using the Boston Criteria v2.0, the corresponding values were 43% (25%-62%), 83% (72%-92%), and 0.63 (0.52-0.74), respectively. No overall performance measures were significantly different between the criteria versions. Secondary analyses using any neuropathologic CAA showed similar patterns. In memory clinic patients, both Boston Criteria versions showed only modest overall diagnostic performance against neuropathology. Compared with v1.5, Boston Criteria v2.0 showed a numerical shift toward greater sensitivity at the expense of specificity but no clear overall gain in accuracy. These findings support cautious, context-dependent interpretation of MRI-based CAA criteria in memory clinic settings and highlight the need for additional biomarkers to improve in vivo diagnosis in nonhemorrhagic populations. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that, in memory clinic populations, Boston Criteria v2.0 show a trade-off between sensitivity and specificity for probable CAA diagnosis, with only modest overall diagnostic accuracy for identifying moderate-to-severe neuropathologically defined CAA.
What this study adds
Evidence grade: Low
In memory clinic patients, both Boston Criteria versions showed only modest overall diagnostic performance against neuropathology, with no clear overall gain in accuracy for the newer version. Reported effect size: 36.2%; AUC 0.59.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kropp, E., Varkanitsa, M., Stein, T. D., Turk, K. W., Alosco, M. L., Tripodis, Y., et al. (2026). Diagnostic Accuracy of the Boston Criteria v2.0 in Memory Clinic Patients. Neurology. https://doi.org/10.1212/wnl.0000000000218314
Vancouver
Kropp E, Varkanitsa M, Stein TD, Turk KW, Alosco ML, Tripodis Y, et al. Diagnostic Accuracy of the Boston Criteria v2.0 in Memory Clinic Patients. Neurology. 2026. doi:10.1212/wnl.0000000000218314. PMID: 42546232.
BibTeX
@article{kropp2026-42546232,
author = {Kropp, Emerson and Varkanitsa, Maria and Stein, Thor D. and Turk, Katherine W. and Alosco, Michael Louis and Tripodis, Yorghos and Romero, Jose Rafael and Kiran, Swathi and others},
title = {{Diagnostic Accuracy of the Boston Criteria v2.0 in Memory Clinic Patients}},
journal = {Neurology},
year = {2026},
doi = {10.1212/wnl.0000000000218314},
pmid = {42546232},
url = {https://doi.org/10.1212/wnl.0000000000218314}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Eighty patients were included (mean age: 81 years, interquartile range 74-86 years; 36.2% female, ∼80% with dementia and Alzheimer disease).
- Using moderate-to-severe CAA as the neuropathologic reference standard, probable CAA by Boston Criteria v1.5 had a sensitivity of 32% (95% CI 15%-50%), specificity 87% (77%-95%), and AUC 0.59 (0.49-0.69).
- Using the Boston Criteria v2.0, the corresponding values were 43% (25%-62%), 83% (72%-92%), and 0.63 (0.52-0.74), respectively.
- No overall performance measures were significantly different between the criteria versions.
- Secondary analyses using any neuropathologic CAA showed similar patterns.
Why it matters
In memory clinic patients, both Boston Criteria versions showed only modest overall diagnostic performance against neuropathology, with no clear overall gain in accuracy for the newer version. These findings support cautious interpretation of MRI-based criteria and highlight the need for additional biomarkers.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Effect size36.2%; AUC 0.59
- Evidence strengthLow
How this study scored 45/100
Published in a leading specialty journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 4 / 6 | Cited 8.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Andreas Charidimou: h-index 72 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Boston University: institution h-index 1,456 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42546232) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Getting a diagnosis from nearby years
Also tagged “mini-mental”
840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.